Navigation Links
Nutra Pharma Completes FDA Submission for Nyloxin OTC and Nyloxin Rx -- Over-the-Counter and Prescription Treatments for Chronic Pain
Date:12/7/2009

loxin Rx in October as a prescription treatment for severe (Stage 3) chronic pain. Unlike Stage 2 pain, which interferes with both work and sleep, Nyloxin Rx is aimed at treating the most severe pain that inhibits one’s ability to fully function.

Both Nyloxin OTC and Nyloxin Rx are produced by Nutra Pharma’s wholly-owned drug discovery subsidiary, ReceptoPharm, and do not rely on the use of opioids or acetaminophen for their pain relieving action.

About Nutra Pharma Corp.
Nutra Pharma Corp. is a biopharmaceutical company specializing in the acquisition, licensing and commercialization of pharmaceutical products and technologies for the management of neurological disorders, cancer, autoimmune and infectious diseases. Nutra Pharma Corp. through its subsidiaries carries out basic drug discovery research and clinical development and also seeks strategic licensing partnerships to reduce the risks associated with the drug development process. The Company's subsidiary, ReceptoPharm, Inc., is developing these technologies for the production of drugs for HIV and Multiple Sclerosis ("MS"). The Company's subsidiary, Designer Diagnostics, is engaged in the research and development of diagnostic test kits designed to be used for the rapid identification of infectious diseases such as Paratuberculosis (para-TB) and Mycobacterium avium-intracellulare (MAI). Nutra Pharma continues to identify and acquire intellectual property and companies in the biotechnology arena.

http://www.NutraPharma.com
http://www.ReceptoPharm.com
http://www.Nyloxin.com

SEC Disclaimer
This press release contains forward-looking statements. The words or phras
'/>"/>

Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Page: 1 2 3

Related medicine news :

1. Nutra Pharma Announces Upcoming Webinar to Discuss the Company's Over-the-Counter (OTC) and Prescription Treatments for Chronic Pain
2. Reportlinker Adds Key Players and Innovative Start-Ups in Nutraceuticals: Emerging Strategies in Ingredients, Pharma, Food and Drinks
3. Nutra Pharma Introduces Chronic Pain Reliever, Nyloxin OTC, for International Distribution
4. Nutra Pharma Announces Plans to Begin Drug Registration Process in South America for its Over-the-Counter Pain Reliever
5. Vivakor Presents at Nutraceutical Event
6. Reportlinker Adds US World Nutraceutical Ingredients Industry
7. RZN Nutraceuticals Receives United States Patent & Trademark Office Notice of Allowance for Proprietary HerbaZorb(TM) Absorption and Delivery System Technology Used in Popular Arthri-Zen Relief(R) and Migra-Zen Relief PLUS(R) Products
8. Star Scientific Files Second Quarter Financial Results; Rock Creek Pharmaceuticals Reports Early Promising Results in Studies Assessing Safety and Viability of Active Components for a Non-Nicotine Nutraceutical (CigRx(TM))
9. NutraCea Announces Forbearance Agreement With Bank and Provides Update on Business Strategy and Transactions
10. NutraCea Announces Additions to Management Team; Chief Operating Officer Extends Employment Contract
11. Nutraceutical Reports Fiscal 2009 Q3 Results and Expands Share Repurchase Program
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Nutra Pharma Completes FDA Submission for Nyloxin OTC and Nyloxin Rx -- Over-the-Counter and Prescription Treatments for Chronic Pain
(Date:3/3/2015)... The Rheumatology Nurses Society (RNS) is ... and safe practice for patients with rheumatic diseases. , ... infusions are administered in an infusion center, provider’s office, ... nurse (RN), as defined in their State Nurse Practice ... receiving these medications during a first infusion, as well ...
(Date:3/3/2015)... Dr. Michael Nochomovitz has ... clinical integration and network development officer for ... established role, Dr. Nochomovitz is responsible for ... physician enterprise, its integration within NewYork-Presbyterian and ... Physicians. , Dr. Nochomovitz brings 17 years ...
(Date:3/3/2015)... NY (PRWEB) March 03, 2015 Topical BioMedics, ... as a webinar streamed live on Tuesday, March 10th, 12pm ... will be archived and accessible 24/7. , ... public. The topic for the March 10th workshop is “Opioid ... discussion, considering that the U.S. represents 5% of the world’s ...
(Date:3/3/2015)... March 03, 2015 The number of ... 1984 to about 15%. This increases to 50% by ... T, Cook JL, Yuzpe AA, et al. Estimating the ... 738-46). Dr. Jason Hitkari, a reproductive endocrinologist and co-director ... of TCM and clinical director and founder of Acubalance ...
(Date:3/3/2015)... Introducing 3D Digital Technologies to their state-of-the-art facilities, ... Digital Dentistry. Acute precision in 3D Digital ... no room for error during the manufacturing process. ... to significantly reduce “chair time” and cut material ... reducing labor and material costs proving to be ...
Breaking Medicine News(10 mins):Health News:Administration of Biologic Infusions: A Position Statement of the Rheumatology Nurses Society 2Health News:Dr. Michael Nochomovitz to Lead Clinical Integration and Network Development for the NewYork-Presbyterian Healthcare System 2Health News:Dr. Michael Nochomovitz to Lead Clinical Integration and Network Development for the NewYork-Presbyterian Healthcare System 3Health News:Dr. Michael Nochomovitz to Lead Clinical Integration and Network Development for the NewYork-Presbyterian Healthcare System 4Health News:Topical BioMedics Hosts March Pain Management Webinar 2Health News:Topical BioMedics Hosts March Pain Management Webinar 3Health News:Topical BioMedics Hosts March Pain Management Webinar 4Health News:Topical BioMedics Hosts March Pain Management Webinar 5Health News:New Treatment Approach Helps Boost Chance of Pregnancy; Information Seminar at Olive Fertility Center 2Health News:New Treatment Approach Helps Boost Chance of Pregnancy; Information Seminar at Olive Fertility Center 3Health News:New Treatment Approach Helps Boost Chance of Pregnancy; Information Seminar at Olive Fertility Center 4Health News:Iverson Dental Labs Introduces 3D Digital Dental Technology for Superior Products 2Health News:Iverson Dental Labs Introduces 3D Digital Dental Technology for Superior Products 3
... Agency advises against everything but jars of peanut butter ... Keebler peanut butter cookies; toll at 453 sickened, 6 ... 17 (HealthDay News) -- The U.S. Food and Drug ... butter products containing peanut butter or peanut butter paste, ...
... peanut butter cookies; FDA asks more companies to test ... sick in 43 states and 1 in Canada, and ... -- Cereal giant Kellogg recalled 16 products containing peanut ... investigation into peanut products possibly contaminated with salmonella. , ...
... chance to win up to $2,500 and promote colon-cancer ... Hutchinson Cancer Research Center,s "Get Screened" video contest - ... the importance of colorectal-cancer screening - has been extended ... Center,s ongoing awareness campaign - "Your colon. Your ...
... Jan. 16 Crdentia Corporation (the "Company") today has ... the Company,s non-reporting status. In conjunction with this, ... conjunction with its transfer agent, Computershare. All share ... listed below for reissuance of new share certificates, although ...
... ARLINGTON, Va., Jan. 16 Despite growing numbers on the ... involved in fatal collisions during 1997-2006 than in years past, ... deaths among drivers 70 and older fell 21 percent during ... of people 70 and older rose 10 percent. Compared with ...
... KJT Group announces a former Harris Interactive executive has joined ... pleased to announce the appointment of J. Scott Moller, M.S. ... Rochester, Mr. Moller has a BA in Economics and Political ... Analysis from the University of Rochester . Before ...
Cached Medicine News:Health News:FDA Warns Consumers Not to Eat Peanut Butter Products 2Health News:FDA Warns Consumers Not to Eat Peanut Butter Products 3Health News:FDA Warns Consumers Not to Eat Peanut Butter Products 4Health News:Kellogg Recalls 16 Products as Salmonella Probe Widens 2Health News:Kellogg Recalls 16 Products as Salmonella Probe Widens 3Health News:Kellogg Recalls 16 Products as Salmonella Probe Widens 4Health News:'Get Screened' Video Contest Deadline Extended to Jan. 30 2Health News:Crdentia Corp. Finalizes Reverse Stock Split 2Health News:Contrary to Earlier Predictions, Older Driver Fatal Crashes Trend Down 2Health News:Contrary to Earlier Predictions, Older Driver Fatal Crashes Trend Down 3Health News:KJT Group L.L.C. Continues Solid Growth 2
(Date:3/3/2015)... , March 3, 2015 Dr. Cummins is ... greatest leaders in aesthetics. In addition to performing ... and Hand Surgery practice, Dr. Cummins now offers advanced ... Removal clinic . Dr. Cummins performs all treatments himself ... founded Louisville Tattoo Removal in order to help people ...
(Date:3/3/2015)... Calif. , March 3, 2015  BioPharmX Corporation ... development of novel drug delivery products to address unmet ... that Jim Pekarsky , chief executive officer and ... Annual Roth Capital Partners Conference on Wednesday, March ... Laguna Niguel in Dana ...
(Date:3/3/2015)... 2015  American Biosurgical, LLC ("ABI") ( www.americanbiosurgical.com ... actively engaged in the design, development and production ... leading medical device companies has announced the acquisition ... custom medical cable manufacturer based in North Carolina.  ... under the name MTI Medical Cables.  ...
Breaking Medicine Technology:Surgeon Owned And Operated Louisville Tattoo Removal Offers Astanza Duality Laser Treatments 2BioPharmX Corporation To Present At 27th Annual Roth Capital Partners Conference On March 11, 2015 2BioPharmX Corporation To Present At 27th Annual Roth Capital Partners Conference On March 11, 2015 3American Biosurgical Acquires MTI Corporation 2
... April 4, 2011 VIVUS, Inc. (Nasdaq: VVUS ... the investigational drug QNEXA® for two years showed reductions in ... as improvements in lipid levels following significant reductions in weight ... two years. The data – additional results ...
... ANGELES, April 4, 2011 NeuroSigma, Inc. ("NeuroSigma"), a ... develop early stage technologies with the potential to transform ... Investor Relations to design and execute its strategic communications ... to working closely with CCG to establish and enhance ...
Cached Medicine Technology:Weight Loss With QNEXA® Over Two Years Provides Patients With Substantial Cardiovascular Benefits 2Weight Loss With QNEXA® Over Two Years Provides Patients With Substantial Cardiovascular Benefits 3NeuroSigma, Inc. Retains CCG Investor Relations 2NeuroSigma, Inc. Retains CCG Investor Relations 3
Complete product line for typing all classical HLA loci including A, B, C DRA, DRB1, DRB3, DRB4, DRB5, DQA, DQB1, DPA1, and DPB1....
... Our Class II Direct to High Res SSP ... with a single tray. Locus specific typing on a ... time. , Straight from genomic DNA to high ... , Allele level typing with a single tray , ...
... Our Class I Direct to High Res SSP ... with a single tray. Locus specific typing on a ... time. , Straight from genomic DNA to high ... , Allele level typing with a single tray , ...
... High Res SSP kits provide high resolution typing of ... typing on a single tray reduces QC and testing ... DNA to high resolution results, no need for initial ... single tray , Unique reaction pattern for most common ...
Medicine Products: